Detection of pseudoprogression with [18F]-FDG-PET in a patient with pulmonary large cell neuroendocrine carcinoma who received anti-PD-1 treatment
Yamaguchi, Ou, Kaira, Kyoichi, Hashimoto, Kosuke, Kagamu, Hiroshi
Published in European journal of nuclear medicine and molecular imaging (01.04.2021)
Published in European journal of nuclear medicine and molecular imaging (01.04.2021)
Get full text
Journal Article
Acute hemorrhagic gastritis after nivolumab treatment
Kobayashi, Masanori, Yamaguchi, Ou, Nagata, Koji, Nonaka, Kouichi, Ryozawa, Shomei
Published in Gastrointestinal endoscopy (01.11.2017)
Published in Gastrointestinal endoscopy (01.11.2017)
Get full text
Journal Article
Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease
Kenmotsu, Hirotsugu, Yoh, Kiyotaka, Mori, Keita, Ono, Akira, Baba, Tomohisa, Fujiwara, Yutaka, Yamaguchi, Ou, Ko, Ryo, Okamoto, Hiroaki, Yamamoto, Nobuyuki, Ninomiya, Takashi, Ogura, Takashi, Kato, Terufumi
Published in Cancer science (01.12.2019)
Published in Cancer science (01.12.2019)
Get full text
Journal Article
Tumor metabolic volume by 18F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50
Yamaguchi, Ou, Kaira, Kyoichi, Hashimoto, Kosuke, Mouri, Atsuto, Shiono, Ayako, Miura, Yu, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, Hiroshi, Kuji, Ichiei
Published in Scientific reports (14.09.2020)
Published in Scientific reports (14.09.2020)
Get full text
Journal Article
Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan
Ohe, Yuichiro, Kato, Terufumi, Sakai, Fumikazu, Kusumoto, Masahiko, Endo, Masahiro, Saito, Yoshinobu, Baba, Tomohisa, Sata, Masafumi, Yamaguchi, Ou, Sakamoto, Kei, Sugeno, Masatoshi, Tamura, Reiko, Tokimoto, Toshimitsu, Shimizu, Wataru, Gemma, Akihiko
Published in Japanese journal of clinical oncology (04.08.2020)
Published in Japanese journal of clinical oncology (04.08.2020)
Get full text
Journal Article
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer
Yamaguchi, Ou, Imai, Hisao, Minemura, Hiroyuki, Suzuki, Kensuke, Wasamoto, Satoshi, Umeda, Yukihiro, Osaki, Takashi, Kasahara, Norimitsu, Uchino, Junji, Sugiyama, Tomohide, Ishihara, Shinichi, Ishii, Hisashi, Naruse, Ichiro, Mori, Keita, Kotake, Mie, Kanazawa, Kenya, Minato, Koichi, Kagamu, Hiroshi, Kaira, Kyoichi
Published in Cancer chemotherapy and pharmacology (01.04.2020)
Published in Cancer chemotherapy and pharmacology (01.04.2020)
Get full text
Journal Article
Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
Miura, Keita, Yamaguchi, Ou, Mori, Keita, Nakamura, Atsushi, Tamiya, Motohiro, Oba, Tomohiro, Yanagitani, Noriko, Mizutani, Hideaki, Ninomiya, Takashi, Kajiwara, Tomosue, Ito, Kentaro, Miyanaga, Akihiko, Arai, Daisuke, Kodama, Hiroaki, Kobayashi, Kunihiko, Kaira, Kyoichi
Published in Scientific reports (15.02.2024)
Published in Scientific reports (15.02.2024)
Get full text
Journal Article
Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancer
Hashimoto, Kosuke, Kaira, Kyoichi, Imai, Hisao, Yamaguchi, Ou, Mouri, Atsuto, Shiono, Ayako, Miura, Yu, Kobayashi, Kunihiko, Kagamu, Hiroshi, Kuji, Ichiei
Published in Cancer imaging (18.11.2024)
Published in Cancer imaging (18.11.2024)
Get full text
Journal Article
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
Yamaguchi, Ou, Kasahara, Norimitsu, Soda, Hiroshi, Imai, Hisao, Naruse, Ichiro, Yamaguchi, Hiroyuki, Itai, Miki, Taguchi, Kohei, Uchida, Megumi, Sunaga, Noriaki, Maeno, Toshitaka, Minato, Koichi, Tomono, Hiromi, Ogawara, Daiki, Mukae, Hiroshi, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Kagamu, Hiroshi, Kaira, Kyoichi
Published in Scientific reports (27.11.2023)
Published in Scientific reports (27.11.2023)
Get full text
Journal Article
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027
Minegishi, Yuji, Yamaguchi, Ou, Sugawara, Shunichi, Kuyama, Shoichi, Watanabe, Satoshi, Usui, Kazuhiro, Mori, Masahide, Hataji, Osamu, Nukiwa, Toshihiro, Morita, Satoshi, Kobayashi, Kunihiko, Gemma, Akihiko
Published in BMC cancer (01.03.2021)
Published in BMC cancer (01.03.2021)
Get full text
Journal Article
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients
Shiono, Ayako, Kaira, Kyoichi, Mouri, Atsuto, Yamaguchi, Ou, Hashimoto, Kosuke, Uchida, Takahiro, Miura, Yu, Nishihara, Fuyumi, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, Hiroshi
Published in Thoracic cancer (01.04.2019)
Published in Thoracic cancer (01.04.2019)
Get full text
Journal Article
Establishing a whole blood CD4 + T cell immunity measurement to predict response to anti-PD-1
Yamaguchi, Ou, Atarashi, Kazuyuki, Yoshimura, Kenichi, Shiono, Ayako, Mouri, Atsuhito, Nishihara, Fuyumi, Miura, Yu, Hashimoto, Kosuke, Miyamoto, Yoshiaki, Uga, Hitoshi, Seki, Nobuo, Matsushima, Tomoko, Kikukawa, Norihiro, Kobayashi, Kunihiko, Kaira, Kyoichi, Kagamu, Hiroshi
Published in BMC cancer (17.12.2022)
Published in BMC cancer (17.12.2022)
Get full text
Journal Article
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Imai, Hisao, Wasamoto, Satoshi, Yamaguchi, Ou, Suzuki, Kensuke, Sugiyama, Tomohide, Uchino, Junji, Minemura, Hiroyuki, Osaki, Takashi, Ishii, Hisashi, Umeda, Yukihiro, Mori, Keita, Kotake, Mie, Kagamu, Hiroshi, Morozumi, Nobutoshi, Taniguchi, Hirokazu, Kasai, Takashi, Minato, Koichi, Kaira, Kyoichi
Published in Journal of cancer research and clinical oncology (01.02.2020)
Published in Journal of cancer research and clinical oncology (01.02.2020)
Get full text
Journal Article
Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer
Kaira, Kyoichi, Yamaguchi, Ou, Kawasaki, Tomonori, Hashimoto, Kousuke, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Imai, Hisao, Kobayashi, Kunihiko, Yasuda, Masanori, Kagamu, Hiroshi
Published in Discover. Oncology (20.01.2023)
Published in Discover. Oncology (20.01.2023)
Get full text
Journal Article
Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer
Imai, Hisao, Kishikawa, Takayuki, Minemura, Hiroyuki, Yamada, Yutaka, Ibe, Tatsuya, Yamaguchi, Ou, Mouri, Atsuto, Hamamoto, Yoichiro, Kanazawa, Kenya, Kasai, Takashi, Kaira, Kyoichi, Kaburagi, Takayuki, Minato, Koichi, Kobayashi, Kunihiko, Kagamu, Hiroshi
Published in Cancer medicine (Malden, MA) (01.10.2021)
Published in Cancer medicine (Malden, MA) (01.10.2021)
Get full text
Journal Article
Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer
Yamaguchi, Ou, Kaira, Kyoichi, Naruse, Ichiro, Umeda, Yukihiro, Honda, Takeshi, Watanabe, Satoshi, Ichikawa, Kosuke, Tateishi, Kazunari, Kasahara, Norimitsu, Higuchi, Tetsuya, Hashimoto, Kosuke, Shinomiya, Shun, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Imai, Hisao, Iizuka, Kunihiko, Ishizuka, Tamotsu, Minato, Koichi, Suda, Satoshi, Kagamu, Hiroshi, Mori, Keita, Kuji, Ichiei, Seki, Nobuhiko
Published in Scientific reports (12.07.2022)
Published in Scientific reports (12.07.2022)
Get full text
Journal Article
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
Fujimoto, Daichi, Miura, Satoru, Tomii, Keisuke, Sumikawa, Hiromitsu, Yoshimura, Kenichi, Wakuda, Kazushige, Oya, Yuko, Yokoyama, Toshihide, Kijima, Takashi, Asao, Tetsuhiko, Tamiya, Motohiro, Nakamura, Atsushi, Yoshioka, Hiroshige, Tokito, Takaaki, Murakami, Shuji, Tamiya, Akihiro, Yokouchi, Hiroshi, Watanabe, Satoshi, Yamaguchi, Ou, Morinaga, Ryotaro, Jodai, Takayuki, Ito, Kentaro, Shiraishi, Yoshimasa, Kogure, Yoshihito, Shibaki, Ryota, Yamamoto, Nobuyuki
Published in Scientific reports (06.03.2023)
Published in Scientific reports (06.03.2023)
Get full text
Journal Article
Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab
Yamaguchi, Ou, Kaira, Kyoichi, Hashimoto, Kosuke, Mouri, Atsuto, Miura, Yu, Shiono, Ayako, Nishihara, Fuyumi, Murayama, Yoshitake, Noda, Shin‐ei, Kato, Shingo, Kobayashi, Kunihiko, Kagamu, Hiroshi
Published in Thoracic cancer (01.04.2019)
Published in Thoracic cancer (01.04.2019)
Get full text
Journal Article
Real‐world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive‐disease small‐cell lung cancer
Shiono, Ayako, Imai, Hisao, Wasamoto, Satoshi, Tsuda, Takeshi, Nagai, Yoshiaki, Minemura, Hiroyuki, Yamada, Yutaka, Kishikawa, Takayuki, Umeda, Yukihiro, Takechi, Hiroki, Yamaguchi, Ou, Mouri, Atsuto, Kaira, Kyoichi, Taniguchi, Hirokazu, Minato, Koichi, Kagamu, Hiroshi
Published in Cancer medicine (Malden, MA) (01.01.2023)
Published in Cancer medicine (Malden, MA) (01.01.2023)
Get full text
Journal Article